Resurgence of measles in a country of elimination: interim assessment and current control measures in the Republic of Korea in early 2014 | Zendy

Tae Un Yang | Zendy; Ju Whi Kim | Zendy; Hye Eun Eom | Zendy; Hyun Kyung Oh | Zendy; Eun Seong Kim | Zendy; Hae Ji Kang | Zendy; Jeong-Gu Nam | Zendy; Ki Soon Kim | Zendy; Sung Soon Kim | Zendy; Chan Kyu Lee | Zendy; Young Joon Park | Zendy; Ok Park | Zendy

Open Access

Resurgence of measles in a country of elimination: interim assessment and current control measures in the Republic of Korea in early 2014

Author(s) -

Tae Un Yang,

Ju Whi Kim,

Hye Eun Eom,

Hyun Kyung Oh,

Eun Seong Kim,

Hae Ji Kang,

Jeong-Gu Nam,

Ki Soon Kim,

Sung Soon Kim,

Chan Kyu Lee,

Young Joon Park,

Ok Park

Publication year - 2014

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2014.09.016

Subject(s) - measles , interim , medicine , measles virus , environmental health , isolation (microbiology) , measles vaccine , epidemiology , virology , economic growth , political science , vaccination , biology , economics , microbiology and biotechnology , law

Since the beginning of 2014, the Republic of Korea has experienced a resurgence of measles cases. Among the 220 cases confirmed as measles during epidemiological weeks 1-20 (December 29, 2013 to May 17, 2014), 10 imported cases were identified. The predominant genotype was B3, which reflects the circulating measles virus in adjacent countries. Even with the verification of measles elimination in March 2014 by the World Health Organization, recent importation has been related to international travel. Targeted control measures have been implemented in addition to proper isolation and patient care. A vigilant surveillance system and high levels of vaccine coverage should be maintained to sustain the measles elimination status.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research